These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1335079)

  • 1. Antirhinoviral activity of heterocyclic analogs of Win 54954.
    Bailey TR; Diana GD; Kowalczyk PJ; Akullian V; Eissenstat MA; Cutcliffe D; Mallamo JP; Carabateas PM; Pevear DC
    J Med Chem; 1992 Nov; 35(24):4628-33. PubMed ID: 1335079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipicornavirus activity of tetrazole analogues related to disoxaril.
    Diana GD; Cutcliffe D; Volkots DL; Mallamo JP; Bailey TR; Vescio N; Oglesby RC; Nitz TJ; Wetzel J; Giranda V
    J Med Chem; 1993 Oct; 36(22):3240-50. PubMed ID: 8230114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disoxaril-related 3-(diethylamino)-5-phenylisoxazoles.
    Mazzei M; Dondero R; Ledda B; Demontis F; Vargiu L
    Farmaco; 2000 Feb; 55(2):119-24. PubMed ID: 10782382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antirhinovirus activity of 3-(diethylamino)-5-phenylisoxazole derivatives.
    Mazzei M; Garzoglio R; Balbi A; Grandi T; De Montis A; Corrias S; La Colla P
    Farmaco; 1996 May; 51(5):351-9. PubMed ID: 8767845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformationally restricted analogues of disoxaril: a comparison of the activity against human rhinovirus types 14 and 1A.
    Mallamo JP; Diana GD; Pevear DC; Dutko FJ; Chapman MS; Kim KH; Minor I; Oliveira M; Rossmann MG
    J Med Chem; 1992 Dec; 35(25):4690-5. PubMed ID: 1335081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity studies of 5-[[4-(4,5-dihydro-2-oxazolyl) phenoxy]alkyl]-3-methylisoxazoles: inhibitors of picornavirus uncoating.
    Diana GD; Oglesby RC; Akullian V; Carabateas PM; Cutcliffe D; Mallamo JP; Otto MJ; McKinlay MA; Maliski EG; Michalec SJ
    J Med Chem; 1987 Feb; 30(2):383-8. PubMed ID: 3027340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements.
    Dragovich PS; Prins TJ; Zhou R; Webber SE; Marakovits JT; Fuhrman SA; Patick AK; Matthews DA; Lee CA; Ford CE; Burke BJ; Rejto PA; Hendrickson TF; Tuntland T; Brown EL; Meador JW; Ferre RA; Harr JE; Kosa MB; Worland ST
    J Med Chem; 1999 Apr; 42(7):1213-24. PubMed ID: 10197965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the antirhinoviral activity of acetylfuran replacements for 3-methylisoxazoles. Are 2-acetylfurans bioisosteres for 3-methylisoxazoles?
    Bailey TR; Diana GD; Mallamo JP; Vescio N; Draper TL; Carabateas PM; Long MA; Giranda VL; Dutko FJ; Pevear DC
    J Med Chem; 1994 Nov; 37(24):4177-84. PubMed ID: 7990117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model for compounds active against human rhinovirus-14 based on X-ray crystallography data.
    Diana GD; Treasurywala AM; Bailey TR; Oglesby RC; Pevear DC; Dutko FJ
    J Med Chem; 1990 May; 33(5):1306-11. PubMed ID: 2158559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative structure-activity relationship studies of [(biphenyloxy)propyl]isoxazole derivatives. Inhibitors of human rhinovirus 2 replication.
    Kuz'min VE; Artemenko AG; Muratov EN; Volineckaya IL; Makarov VA; Riabova OB; Wutzler P; Schmidtke M
    J Med Chem; 2007 Aug; 50(17):4205-13. PubMed ID: 17665898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CoMFA analysis of the interactions of antipicornavirus compounds in the binding pocket of human rhinovirus-14.
    Diana GD; Kowalczyk P; Treasurywala AM; Oglesby RC; Pevear DC; Dutko FJ
    J Med Chem; 1992 Mar; 35(6):1002-8. PubMed ID: 1313108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization of human rhinovirus serotype 2 against pH-induced conformational change by antiviral compounds.
    Gruenberger M; Pevear D; Diana GD; Kuechler E; Blaas D
    J Gen Virol; 1991 Feb; 72 ( Pt 2)():431-3. PubMed ID: 1847178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity studies of some disubstituted phenylisoxazoles against human picornavirus.
    Diana GD; Cutcliffe D; Oglesby RC; Otto MJ; Mallamo JP; Akullian V; McKinlay MA
    J Med Chem; 1989 Feb; 32(2):450-5. PubMed ID: 2913305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxadiazoles as ester bioisosteric replacements in compounds related to disoxaril. Antirhinovirus activity.
    Diana GD; Volkots DL; Nitz TJ; Bailey TR; Long MA; Vescio N; Aldous S; Pevear DC; Dutko FJ
    J Med Chem; 1994 Jul; 37(15):2421-36. PubMed ID: 8057290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel [(biphenyloxy)propyl]isoxazole derivatives for inhibition of human rhinovirus 2 and coxsackievirus B3 replication.
    Makarov VA; Riabova OB; Granik VG; Wutzler P; Schmidtke M
    J Antimicrob Chemother; 2005 Apr; 55(4):483-8. PubMed ID: 15743897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [(Biaryloxy)alkyl]isoxazoles: picornavirus inhibitors.
    Guiles JW; Diana GD; Pevear DC
    J Med Chem; 1995 Jul; 38(14):2780-3. PubMed ID: 7629816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding affinities of structurally related human rhinovirus capsid-binding compounds are related to their activities against human rhinovirus type 14.
    Fox MP; McKinlay MA; Diana GD; Dutko FJ
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1040-7. PubMed ID: 1656851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular dynamics simulations of human rhinovirus and an antiviral compound.
    Speelman B; Brooks BR; Post CB
    Biophys J; 2001 Jan; 80(1):121-9. PubMed ID: 11159387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoxazoles with antipicornavirus activity.
    Diana GD; McKinlay MA; Brisson CJ; Zalay ES; Miralles JV; Salvador UJ
    J Med Chem; 1985 Jun; 28(6):748-52. PubMed ID: 2989517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pentamer channel stiffening model for drug action on human rhinovirus HRV-1A.
    Vaidehi N; Goddard WA
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2466-71. PubMed ID: 9122218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.